Although the global burden of leptospirosis remains enormous and new aspects of the disease are constantly recognised, little progress has been achieved in the field of leptospirosis therapeutics and queries regarding the utility of antibiotics in the late severe form of the disease remain. From the currently existing data, conclusions on the efficacy of antibiotic administration in severe or late disease cannot easily be drawn, since clinical trials have different selection criteria and may focus on Leptospira serovars with different virulence. However, as a rule the benefit of the doubt should apply. Moreover, new options, such as ceftriaxone, have a superior safety profile to penicillin. In vitro studies have outlined potential antimicrobial candidates such as macrolides and ketolides. Development of a globally accepted subunit vaccine for humans is warranted but is not expected in the near future

PAPPAS G, CASCIO A. (2006). Optimal treatment of leptospirosis: queries and projections. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 28, 491-496 [10.1016/j.ijantimicag.2006.08.021].

Optimal treatment of leptospirosis: queries and projections

CASCIO A.
2006-01-01

Abstract

Although the global burden of leptospirosis remains enormous and new aspects of the disease are constantly recognised, little progress has been achieved in the field of leptospirosis therapeutics and queries regarding the utility of antibiotics in the late severe form of the disease remain. From the currently existing data, conclusions on the efficacy of antibiotic administration in severe or late disease cannot easily be drawn, since clinical trials have different selection criteria and may focus on Leptospira serovars with different virulence. However, as a rule the benefit of the doubt should apply. Moreover, new options, such as ceftriaxone, have a superior safety profile to penicillin. In vitro studies have outlined potential antimicrobial candidates such as macrolides and ketolides. Development of a globally accepted subunit vaccine for humans is warranted but is not expected in the near future
PAPPAS G, CASCIO A. (2006). Optimal treatment of leptospirosis: queries and projections. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 28, 491-496 [10.1016/j.ijantimicag.2006.08.021].
File in questo prodotto:
File Dimensione Formato  
Optimal treatment of leptospirosis queries and projections.pdf

Solo gestori archvio

Dimensione 108.77 kB
Formato Adobe PDF
108.77 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/383349
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 40
  • ???jsp.display-item.citation.isi??? 28
social impact